Enterprise Value
1.705B
Cash
224.6M
Avg Qtr Burn
-14.93M
Short % of Float
13.73%
Insider Ownership
0.10%
Institutional Own.
41.29%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 2a Data readout | ||
ANPA-0073 (APJ agonist) Details Idiopathic pulmonary fibrosis, Pulmonary arterial hypertension | Phase 1 Update |